178 related articles for article (PubMed ID: 19414363)
1. Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma.
Cardoso SV; Silveira-Júnior JB; De Carvalho Machado V; De-Paula AM; Loyola AM; De Aguiar MC
Anticancer Res; 2009 Apr; 29(4):1189-93. PubMed ID: 19414363
[TBL] [Abstract][Full Text] [Related]
2. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of metallothionein on oral squamous cell carcinoma.
Cardoso SV; Barbosa HM; Candellori IM; Loyola AM; Aguiar MC
Virchows Arch; 2002 Aug; 441(2):174-8. PubMed ID: 12189508
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metallothionein and p53 expression as potential prognostic markers for laryngeal squamous cell carcinoma.
Brown JJ; Xu H; William-Smith L; Mohamed H; Teklehaimanot S; Zhuo J; Osborne R; Liu F; Gowans RE; Nishitani J; Liu X
Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL473-9. PubMed ID: 14995078
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression and prognostic significance of TIMP-1 and -2 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; López Arranz JS
Oral Oncol; 2005 Jul; 41(6):568-79. PubMed ID: 15925538
[TBL] [Abstract][Full Text] [Related]
7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma.
de Oliveira LR; Ribeiro-Silva A; Zucoloto S
J Oral Pathol Med; 2007 Apr; 36(4):191-7. PubMed ID: 17391296
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis.
Soni S; Pande P; Shukla NK; Ralhan R
J Cancer Res Clin Oncol; 2002 Jun; 128(6):336-42. PubMed ID: 12073053
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of oral squamous cell carcinoma: a tissue microarray study.
Solomon MC; Carnelio S; Gudattu V
Indian J Cancer; 2010; 47(2):166-72. PubMed ID: 20448381
[TBL] [Abstract][Full Text] [Related]
12. Primary tumours neoangiogenesis and P53 expression in oral carcinoma patients.
Grammatica L; Piepoli S; D'Auria C; Achille G; Marzullo F; Zito FA; Labriola A; Salvatore C; Paradiso A
J Exp Clin Cancer Res; 2001 Jun; 20(2):225-30. PubMed ID: 11484979
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas.
Chen Q; Zhou H; Guo W; Samaranayake LP; Zhou M; Li B
Cytobios; 2001; 106(412):87-99. PubMed ID: 11503976
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
17. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients.
Warnakulasuriya S; Soussi T; Maher R; Johnson N; Tavassoli M
J Pathol; 2000 Sep; 192(1):52-7. PubMed ID: 10951400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
